Latest News and Press Releases
Want to stay updated on the latest news?
-
Ready to start pivotal Phase III clinical trial Allecra secures Series C €14M financing from existing shareholdersDr. Klaus Wilgenbus appointed as CEO and Dr. Mathias Knecht as second Managing...
-
LÖRRACH, Germany and SAINT LOUIS, France, April 17, 2018 (GLOBE NEWSWIRE) -- Allecra Therapeutics (Private), a biopharmaceutical company focused on developing and commercializing novel...
-
LÖRRACH, Germany and SAINT LOUIS, France, April 03, 2018 (GLOBE NEWSWIRE) -- Allecra Therapeutics (Private), today announced it will be featured as a presenting company at the H.C. Wainwright...